A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

Clinical trial NCT02812875 · COMPLETED

Trial details

NCT number: NCT02812875
Sponsor: Curis, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors or Lymphomas

Start date: 2016-05-01
Primary completion: 2020-05-07
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.